• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Yeast Beta Glucan Market

    ID: MRFR/F-B & N/31363-HCR
    111 Pages
    Varsha More
    October 2025

    Yeast Beta Glucan Market Research Report By Application (Food Industry, Pharmaceuticals, Nutraceuticals, Cosmetics, Animal Feed), By Source (Saccharomyces Cerevisiae, Candida Utilis, Pichia Pastoris, Kluyveromyces Lactis), By Form (Powder, Liquid, Granules), By Functionality (Immunomodulatory, Antioxidant, Cholesterol Reduction, Digestive Health) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Yeast Beta Glucan Market
 Infographic
    Purchase Options

    Yeast Beta Glucan Market Summary

    As per MRFR analysis, the Yeast Beta Glucan Market Size was estimated at 0.7901 USD Billion in 2024. The Yeast Beta Glucan industry is projected to grow from 0.839 in 2025 to 1.528 by 2035, exhibiting a compound annual growth rate (CAGR) of 6.18 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    <p>The Yeast Beta Glucan Market is experiencing robust growth driven by health trends and technological advancements.</p>

    • North America remains the largest market for yeast beta glucan, driven by increasing health consciousness among consumers.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by a rising interest in natural ingredients and functional foods.
    • The food industry continues to dominate the market, while the pharmaceuticals segment is witnessing the fastest growth due to expanding applications.
    • Key market drivers include the increasing demand for functional foods and the growth in the sports nutrition sector, which are shaping market dynamics.

    Market Size & Forecast

    2024 Market Size 0.7901 (USD Billion)
    2035 Market Size 1.528 (USD Billion)
    CAGR (2025 - 2035) 6.18%

    Major Players

    Kerry Group (IE), Nutraceutical Corporation (US), Lesaffre (FR), Baker's Yeast (US), ABF Ingredients (GB), Biotec Pharmacon (NO), Fungi Perfecti (US), Mannatech (US), Kemin Industries (US)

    Yeast Beta Glucan Market Trends

    The Yeast Beta Glucan Market is currently experiencing a notable transformation, driven by increasing awareness of health benefits associated with beta glucans. These polysaccharides, derived from yeast cell walls, are recognized for their potential to enhance immune function and support overall wellness. As consumers become more health-conscious, the demand for natural and functional ingredients in food and dietary supplements is on the rise. This trend is further fueled by a growing inclination towards preventive healthcare, leading to a surge in product formulations that incorporate yeast beta glucan. Additionally, the food and beverage sector is witnessing a shift towards clean label products, which emphasizes transparency and the use of recognizable ingredients. Moreover, the Yeast Beta Glucan Market is likely to benefit from advancements in extraction and processing technologies. These innovations may enhance the bioavailability and efficacy of beta glucans, making them more appealing to manufacturers and consumers alike. The increasing application of yeast beta glucan in various industries, including pharmaceuticals and cosmetics, suggests a broadening scope of utilization. As research continues to unveil the multifaceted benefits of yeast beta glucan, its integration into diverse product categories appears promising, potentially leading to sustained growth in the market.

    Rising Health Consciousness

    The growing awareness of health and wellness among consumers is driving the demand for yeast beta glucan. This trend reflects a shift towards preventive health measures, with individuals seeking natural ingredients that support immune function and overall well-being.

    Clean Label Movement

    The Yeast Beta Glucan Market is influenced by the clean label trend, where consumers prefer products with transparent ingredient lists. This movement encourages manufacturers to incorporate recognizable and natural components, enhancing the appeal of yeast beta glucan in food and beverages.

    Technological Advancements

    Innovations in extraction and processing technologies are likely to improve the efficacy and bioavailability of yeast beta glucan. These advancements may facilitate its incorporation into a wider range of applications, including pharmaceuticals and cosmetics.

    The increasing recognition of yeast beta glucan's potential health benefits is driving its adoption across various sectors, particularly in functional foods and dietary supplements.

    U.S. Department of Agriculture

    Yeast Beta Glucan Market Drivers

    Expansion of Nutraceuticals

    The Yeast Beta Glucan Market is witnessing a significant expansion in the nutraceuticals sector, which encompasses dietary supplements and fortified foods. As consumers increasingly prioritize health and wellness, the demand for nutraceutical products containing yeast beta glucan is likely to rise. This ingredient is valued for its potential to support immune function and improve gut health, making it a desirable addition to various supplements. Recent market analysis suggests that the nutraceuticals market is expected to reach a valuation of over 300 billion by 2026, indicating a substantial growth trajectory. This expansion presents a promising avenue for yeast beta glucan, as manufacturers seek to enhance their product offerings with scientifically-backed ingredients that cater to health-conscious consumers.

    Regulatory Support for Health Claims

    The Yeast Beta Glucan Market is poised to benefit from increasing regulatory support for health claims associated with functional ingredients. Regulatory bodies are progressively recognizing the health benefits of yeast beta glucan, particularly its role in immune support and cholesterol management. This recognition is likely to encourage manufacturers to incorporate yeast beta glucan into their products, as they can substantiate health claims with scientific evidence. Recent guidelines from health authorities have paved the way for clearer labeling and marketing of products containing beneficial ingredients. As a result, the market for yeast beta glucan is expected to expand, as consumers become more informed and seek products that offer verifiable health benefits.

    Growth in the Sports Nutrition Sector

    The Yeast Beta Glucan Market is experiencing growth driven by the expanding sports nutrition sector. Athletes and fitness enthusiasts are increasingly seeking supplements that enhance performance and recovery, and yeast beta glucan is gaining attention for its potential benefits in these areas. Research suggests that yeast beta glucan may aid in reducing exercise-induced stress and improving immune response, making it an attractive ingredient for sports nutrition products. The sports nutrition market is projected to grow significantly, with estimates indicating a compound annual growth rate of around 10% over the next few years. This growth presents a valuable opportunity for yeast beta glucan to be integrated into a variety of sports supplements, catering to the needs of health-conscious consumers.

    Increasing Demand for Functional Foods

    The Yeast Beta Glucan Market is experiencing a notable surge in demand for functional foods, driven by consumers' growing awareness of health benefits associated with dietary choices. Functional foods, which are enriched with bioactive compounds, are increasingly sought after for their potential to enhance health and prevent diseases. Yeast beta glucan, recognized for its immune-boosting properties, is becoming a key ingredient in various food products. Market data indicates that the functional food sector is projected to grow at a compound annual growth rate of approximately 8% over the next five years, suggesting a robust opportunity for yeast beta glucan incorporation. This trend reflects a broader shift towards preventive healthcare, where consumers are more inclined to invest in products that promote overall well-being.

    Rising Interest in Natural Ingredients

    The Yeast Beta Glucan Market is benefiting from a rising interest in natural ingredients among consumers. As awareness of synthetic additives and their potential health risks grows, there is a marked shift towards products that feature natural, plant-based components. Yeast beta glucan, derived from yeast cell walls, aligns perfectly with this trend, as it is perceived as a safe and effective natural ingredient. Market Research Future indicates that products labeled as 'natural' are increasingly preferred, with a significant percentage of consumers willing to pay a premium for such items. This inclination towards natural ingredients is likely to bolster the demand for yeast beta glucan in various applications, including food, beverages, and dietary supplements.

    Market Segment Insights

    By By Application: Food Industry (Largest) vs. Pharmaceuticals (Fastest-Growing)

    In the Yeast Beta Glucan Market, the application segmentation reveals the food industry holds the largest share, driven by an increasing consumer inclination towards natural, health-promoting ingredients. The rise in health-consciousness has led to a heightened incorporation of yeast beta glucans in food products for their immune-enhancing properties. In contrast, the pharmaceutical sector is rapidly expanding, emphasizing the potential of yeast beta glucans in enhancing drug formulations and therapeutic applications.

    Food Industry: Dominant vs. Pharmaceuticals: Emerging

    The food industry stands as the dominant application for yeast beta glucans, leveraging their well-established reputation for promoting health benefits such as cholesterol reduction and improved gut health. Products like baked goods, dairy, and beverages are increasingly formulated with this ingredient to meet consumer demands for nutritional enhancement. On the other hand, the pharmaceuticals sector is emerging as a significant force within the market, with yeast beta glucans being integrated for their immunomodulatory effects. This segment is characterized by its innovative product development and ongoing research exploring the efficacy of beta glucans in various therapeutic areas.

    By By Source: Saccharomyces Cerevisiae (Largest) vs. Pichia Pastoris (Fastest-Growing)

    In the Yeast Beta Glucan Market, the source segment exhibits a varied distribution among different yeast species. Saccharomyces Cerevisiae holds the largest market share, attributed to its longstanding application in food and beverage industries, alongside potential health benefits. Meanwhile, other sources like Candida Utilis and Kluyveromyces Lactis also contribute significantly, though at a comparatively smaller scale. The market is characterized by a complex interplay of consumer preferences and regulatory standards influencing the selection of these yeasts. The growth trends within this segment reveal a rising inclination towards health-oriented applications of yeast beta glucan, with Pichia Pastoris emerging as a key player. Its ability to produce beta-glucans efficiently positions it for accelerated growth, enhanced by increasing awareness of health benefits among consumers. Additionally, ongoing innovations and research in yeast applications drive the adoption of these sources in nutraceuticals, functional foods, and industrial applications.

    Saccharomyces Cerevisiae (Dominant) vs. Candida Utilis (Emerging)

    Saccharomyces Cerevisiae is recognized as the dominant player in the Yeast Beta Glucan Market, due to its extensive use in baking and fermentation industries, leading to a strong consumer base. Its well-documented health benefits further bolster its position. In contrast, Candida Utilis, though still considered an emerging source, possesses distinct advantages. It thrives in various substrates, making it a versatile option for diverse applications. While it currently captures a smaller share of the market, its unique properties related to beta-glucan production are gaining attention, suggesting potential for significant growth as health-conscious trends continue to influence consumer preferences and drive innovation in this segment.

    By By Form: Powder (Largest) vs. Liquid (Fastest-Growing)

    The 'By Form' segment within the Yeast Beta Glucan Market showcases a diverse range of products including powder, liquid, and granules. Among these, powder form holds the largest market share due to its widespread use in dietary supplements and functional foods, where it serves as a key ingredient for enhancing health benefits. Liquid form, however, is witnessing rapid growth, attracting attention from formulators in the food and beverage sector who seek to incorporate soluble beta-glucans into their products for improved efficacy.

    Powder (Dominant) vs. Liquid (Emerging)

    Powdered yeast beta glucoan is the dominant form in the market, favored for its versatility and stability in various formulations. It is extensively used in supplements and functional foods, where it can be easily integrated into powder mixes. Conversely, liquid yeast beta glucan is emerging as a popular choice due to its ease of use and ability to be rapidly absorbed into the body. This form is particularly appealing to manufacturers looking to enhance beverage formulations and other liquid products with health-promoting properties. The growth in liquid beta glucan is driven by consumer trends favoring convenience and fortification, making it a segment to watch in the coming years.

    By By Functionality: Immunomodulatory (Largest) vs. Antioxidant (Fastest-Growing)

    In the Yeast Beta Glucan Market, the Immunomodulatory functionality segment leads with a significant market share, reflecting the growing consumer awareness about health benefits associated with immune system enhancement. The Antioxidant functionality segment, while smaller, is rapidly gaining traction as more consumers seek natural ingredients that combat oxidative stress. Both segments contribute to a diverse functional profile that caters to varying health concerns among consumers, shaping the overall landscape of the market.

    Immunomodulatory (Dominant) vs. Antioxidant (Emerging)

    The Immunomodulatory functionality of yeast beta glucan stands out as the dominant player in the market, as it effectively supports immune system health, a paramount consideration for health-conscious consumers. This segment leverages scientific validation and health claims to attract a loyal customer base. On the other hand, the Antioxidant functionality segment is emerging, appealing particularly to younger consumers interested in skincare and overall wellness. As trends shift toward preventive health measures, the demand for antioxidant properties within yeast beta glucan is projected to grow significantly. Both segments complement each other and reflect a broader trend towards holistic health solutions.

    Get more detailed insights about Yeast Beta Glucan Market

    Regional Insights

    North America : Innovation and Demand Surge

    North America is the largest market for yeast beta glucan, holding approximately 40% of the global market share. The region's growth is driven by increasing health awareness, rising demand for dietary supplements, and regulatory support for functional foods. The FDA's recognition of beta glucan as a beneficial ingredient further propels market expansion. Additionally, the trend towards natural and organic products is boosting demand for yeast beta glucan in various applications. The United States and Canada are the leading countries in this region, with the U.S. accounting for a significant portion of the market. Key players such as Kerry Group, Nutraceutical Corporation, and Kemin Industries are actively involved in product innovation and strategic partnerships. The competitive landscape is characterized by a focus on research and development, with companies investing in new formulations to meet consumer preferences for health and wellness products.

    Europe : Regulatory Support and Growth

    Europe is the second-largest market for yeast beta glucan, holding around 30% of the global market share. The region's growth is fueled by increasing consumer awareness regarding health benefits, particularly in immune support and gut health. Regulatory bodies like the European Food Safety Authority (EFSA) have recognized the health claims associated with beta glucan, which encourages manufacturers to incorporate it into their products. The rising trend of clean label products also contributes to market growth. Leading countries in Europe include Germany, France, and the United Kingdom, where the demand for functional foods is on the rise. The competitive landscape features key players such as Lesaffre and ABF Ingredients, who are focusing on innovation and sustainability. The presence of a robust food and beverage industry further enhances the market potential for yeast beta glucan, as manufacturers seek to meet evolving consumer demands.

    Asia-Pacific : Rapid Growth and Opportunities

    Asia-Pacific is witnessing rapid growth in the yeast beta glucan market, accounting for approximately 20% of the global share. The increasing prevalence of lifestyle diseases and a growing focus on preventive healthcare are key drivers of this market. Countries like China and India are experiencing a surge in demand for dietary supplements and functional foods, supported by government initiatives promoting health and wellness. The region's diverse population and rising disposable incomes further enhance market opportunities. China and Japan are the leading countries in this region, with a strong presence of local and international players. Companies such as Fungi Perfecti and Mannatech are expanding their operations to cater to the growing consumer base. The competitive landscape is characterized by a mix of established brands and emerging startups, all vying to capture market share through innovative product offerings and strategic collaborations.

    Middle East and Africa : Untapped Potential and Growth

    The Middle East and Africa region is gradually emerging in the yeast beta glucan market, holding about 10% of the global share. The growth is primarily driven by increasing health consciousness among consumers and a rising demand for natural ingredients in food and beverages. Regulatory frameworks are evolving, with governments encouraging the use of functional ingredients to enhance public health. The region's diverse dietary habits present unique opportunities for yeast beta glucan applications. Leading countries in this region include South Africa and the UAE, where there is a growing interest in health supplements and functional foods. The competitive landscape is still developing, with a few key players like Biotec Pharmacon making strides in the market. As awareness of the health benefits of yeast beta glucan increases, more companies are likely to enter the market, further driving growth and innovation.

    Key Players and Competitive Insights

    The Yeast Beta Glucan Market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding health benefits and the growing demand for natural ingredients in food and dietary supplements. Key players such as Kerry Group (IE), Nutraceutical Corporation (US), and Lesaffre (FR) are strategically positioning themselves through innovation and regional expansion. Kerry Group (IE) focuses on enhancing its product portfolio with advanced formulations, while Nutraceutical Corporation (US) emphasizes partnerships with health-focused brands to broaden its market reach. Lesaffre (FR) is investing in research and development to optimize its yeast-based products, thereby shaping a competitive environment that prioritizes quality and efficacy.

    In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and enhance supply chain efficiency. The market appears moderately fragmented, with several players vying for market share. This fragmentation allows for niche players to thrive, while larger companies leverage their scale to optimize operations and drive innovation. The collective influence of these key players fosters a competitive structure that encourages continuous improvement and adaptation to market demands.

    In August 2025, Kerry Group (IE) announced the launch of a new line of yeast beta glucan products aimed at the functional food sector. This strategic move is significant as it aligns with the rising consumer trend towards health-oriented food products, potentially enhancing Kerry's market share in a rapidly growing segment. The introduction of these products is likely to reinforce the company's commitment to innovation and sustainability, appealing to health-conscious consumers.

    In September 2025, Nutraceutical Corporation (US) entered into a strategic partnership with a leading health supplement brand to co-develop a new range of immune-boosting products featuring yeast beta glucan. This collaboration underscores the importance of partnerships in expanding product offerings and reaching new customer segments. By leveraging the strengths of both companies, this initiative may enhance Nutraceutical's competitive positioning in the market.

    In July 2025, Lesaffre (FR) completed the acquisition of a biotechnology firm specializing in yeast fermentation technologies. This acquisition is poised to enhance Lesaffre's capabilities in producing high-quality yeast beta glucan, thereby strengthening its product portfolio. The integration of advanced fermentation technologies could lead to improved product efficacy and sustainability, aligning with current market trends towards environmentally friendly production methods.

    As of October 2025, the competitive trends in the Yeast Beta Glucan Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in production processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, product innovation, and supply chain reliability, reflecting a broader shift in consumer preferences towards quality and sustainability.

    Key Companies in the Yeast Beta Glucan Market market include

    Industry Developments

    Recent developments in the Yeast Beta Glucan Market illustrate a dynamic landscape marked by growing demand in the nutraceutical and food industries, driven by the increasing awareness of health benefits associated with beta-glucans. Companies like Axiom Foods and Innova Health Products are expanding their product lines to cater to the rising consumer interest in plant-based ingredients and functional foods. Biothera has made strides in enhancing its research to increase the effectiveness of its beta-glucan products. Moreover, Angel Yeast and DSM are pursuing innovation and sustainability initiatives to improve production efficiency.

    In terms of mergers and acquisitions, there has been interest among major players like Cargill and Kerry Group, although specific recent acquisitions or mergers have not been disclosed, indicating a potential shift in strategies. The overall market valuation continues to grow as companies invest in advanced technologies and product development. The rising collaboration among firms is expected to further enhance the efficacy and application of yeast beta-glucans across various market segments, reflecting robust progress in the sector.

    Future Outlook

    Yeast Beta Glucan Market Future Outlook

    The Yeast Beta Glucan Market is projected to grow at a 6.18% CAGR from 2024 to 2035, driven by increasing health awareness and demand for functional foods.

    New opportunities lie in:

    • Development of specialized formulations for immune support products.
    • Expansion into emerging markets with tailored marketing strategies.
    • Partnerships with nutraceutical companies for innovative product lines.

    By 2035, the Yeast Beta Glucan Market is expected to achieve robust growth and enhanced market presence.

    Market Segmentation

    Yeast Beta Glucan Market Form Outlook

    • Powder
    • Liquid
    • Granules

    Yeast Beta Glucan Market Source Outlook

    • Saccharomyces Cerevisiae
    • Candida Utilis
    • Pichia Pastoris
    • Kluyveromyces Lactis

    Yeast Beta Glucan Market Application Outlook

    • Food Industry
    • Pharmaceuticals
    • Nutraceuticals
    • Cosmetics
    • Animal Feed

    Yeast Beta Glucan Market Functionality Outlook

    • Immunomodulatory
    • Antioxidant
    • Cholesterol Reduction
    • Digestive Health

    Report Scope

    MARKET SIZE 20240.7901(USD Billion)
    MARKET SIZE 20250.839(USD Billion)
    MARKET SIZE 20351.528(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)6.18% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesGrowing demand for natural health products enhances opportunities in the Yeast Beta Glucan Market.
    Key Market DynamicsRising demand for natural health products drives innovation and competition in the Yeast Beta Glucan Market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the projected market valuation of the Yeast Beta Glucan Market by 2035?

    The Yeast Beta Glucan Market is projected to reach a valuation of 1.528 USD Billion by 2035.

    What was the market valuation of the Yeast Beta Glucan Market in 2024?

    In 2024, the overall market valuation was 0.7901 USD Billion.

    What is the expected CAGR for the Yeast Beta Glucan Market during the forecast period 2025 - 2035?

    The expected CAGR for the Yeast Beta Glucan Market during the forecast period 2025 - 2035 is 6.18%.

    Which application segment is projected to have the highest valuation in the Yeast Beta Glucan Market?

    The Nutraceuticals segment is projected to grow from 0.25 to 0.5 USD Billion during the forecast period.

    What are the key players in the Yeast Beta Glucan Market?

    Key players in the market include Kerry Group, Nutraceutical Corporation, Lesaffre, and Kemin Industries.

    How does the market for Yeast Beta Glucan in the Food Industry compare to other segments?

    The Food Industry segment is expected to grow from 0.2001 to 0.4 USD Billion, indicating robust demand.

    What is the projected growth for the Powder form of Yeast Beta Glucan?

    The Powder form is anticipated to increase from 0.3951 to 0.7856 USD Billion by 2035.

    Which source of Yeast Beta Glucan is expected to dominate the market?

    Saccharomyces Cerevisiae is expected to dominate, with a projected growth from 0.3151 to 0.6344 USD Billion.

    What functionalities are driving the growth of the Yeast Beta Glucan Market?

    Immunomodulatory and Antioxidant functionalities are key drivers, with projected valuations of 0.3151 to 0.6356 USD Billion and 0.1971 to 0.3965 USD Billion, respectively.

    How does the Animal Feed segment perform in the Yeast Beta Glucan Market?

    The Animal Feed segment is projected to grow from 0.1 to 0.148 USD Billion, reflecting increasing interest in animal health.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions